AzTrials
AzTrials

Postpartum DepressionPACTNCT06046456

Prenatal Affective Cognitive Training to Reduce the Risk of Postpartum Depression (PACT)

A study testing Prenatal Affective CogntiiveTraining in people with Postpartum Depression and Emotional Regulation, run by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Many pregnant women face the risk of experiencing depression after giving birth, especially if they've previously dealt with depression. The goal of this study, is to test if our newly developed Prenatal Affective Cognitive Training (PACT) intervention, can decrease the likelihood of post partum depression. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
What is being tested?
Prenatal Affective CogntiiveTraining
Could I receive a placebo?
No, everyone receives an active treatment
How many people
146 participants
Where
1 siteDenmark
Study dates
10 Jan 2023to Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Second or third trimester pregnancy.
  • Age ≥ 18 years.
  • Ability to speak and read Danish.
  • Either:
  • Negative cognitive bias in emotional reactivity to infant distress (cut-off > 96 on a scale from 0-100).
  • High-risk status according to the Antenatal Risk Questionnaire (ANRQ) which means:
Show all 17Show fewer
  • Personal history of severe mental illness.
  • Experienced childhood emotional, physical, or sexual abuse.
  • Total score on psycho-social risk factors is above the cut-off (> 23).
  • Absence of a personal or family history of mental illness.
  • Absence of negative bias.
  • Three or fewer of the additional risk factors mentioned above.
  • General Exclusion Criteria:
  • Schizophrenia.
  • Current substance use disorder.
  • Score of 9 or more on the Hamilton Depression Rating Scale-6 items (HDRS-6), indicating moderate depression.
  • Pregnant women diagnosed with a personality disorder (note: they will still be included at baseline and follow-up after birth but will be excluded from randomization).

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Anne J Bjertrup, PhD contact

27134839

anne.juul.bjertrup@regionh.dk

Denmark1 site, 1 recruiting
  • Mental Health Services in The Capital Region of Denmark

    Copenhagen, 2000

    Anne J Bjertrup, PhD, 27134839, anne.juul.bjertrup@regionh.dk

    Recruiting

Other trials in Denmark

About this study

Official title: Prenatal Affective Cognitive Training to Reduce the Risk of Postpartum Depression (PACT): Study Protocol for a Randomized Controlled Trial

Many pregnant women face the risk of experiencing depression after giving birth, especially if they've previously dealt with depression.

The goal of this study, is to test if our newly developed Prenatal Affective Cognitive Training (PACT) intervention, can decrease the likelihood of post partum depression. In the study, 226 pregnant women, some of whom are considered high risk due to past mental illness or psycho-social risk factors, will participate. The high-risk women will be divided into two groups. One group will undergo the PACT training, which involves computer and virtual reality exercises spanning five weeks, designed to improve mood and emotional regulation. The other group will receive usual care. The study also involves a low-risk group (n=146), although these individuals are not part of the intervention trial but are merely followed up with the same assessments for background comparisons.The main aim is to observe whether the women who undergo PACT intervention are less prone to depression after childbirth compared to those who do not.

This study has potential to offer a simple, non-invasive method to bolster mental health in expectant mothers, which could also positively impact their infants.

Being tested
Prenatal Affective CogntiiveTraining
Medical subject headings
Depression, Postpartum, Emotional Regulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prenatal Affective CogntiiveTrainingOther

    A psychological intervention using computer- and virtual reality based exercises to modify negative cognitive bias and improve emotion regulation

Study groups in NCT06046456
Study groupRoleWhat they receive
PACTExperimentalReceive the intervention
Receives: Other: Prenatal Affective CogntiiveTraining
CAUNo interventionReceive care as usual, i.e., the standard care provided to pregnant women without any additional experimental interventions. It typically involves routine prenatal care, which may include regular check-ups, medical assessments, and general support from healthcare professionals

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of PPD during the first six months after birth, assessed with the Present State Examination (PSE), which is a part of Schedules for Clinical Assessment in Neuropsychiatry (SCAN)

    The primary outcome is the difference between mothers receiving PACT versus CAU in the incidence of PPD during the first six months after birth, assessed by a clinician blind to group status with the Present State Examination (PSE), which is a part of Schedules for Clinical Assessment in Neuropsychiatry (SCAN)

    Measured: Six months after birth

Secondary outcomes (3)
  1. Change in negative cognitive bias

    Differences between participants receiving PACT and CAU in the change in negatively biased cognitive processing of infant stimuli from baseline to follow-up during pregnancy (T1) as measured with computerized testing

    Measured: In third trimester of pregnancy

  2. Self-rated depressive symptoms

    Differences between participants receiving PACT and CAU in severity of depressive symptoms during the first six weeks after birth measured with the Edinburgh Postpartum Depression Scale

    Measured: Within six weeks after birth

  3. Self-rated parental stress

    Self-rated parental stress with the Parental Stress Scale at six months after birth.

    Measured: Six months after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2023
  2. Study start10 Jan 2023
  3. Primary completionFeb 2025 (estimated)
  4. Study completionJul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
146 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06046456
Sponsor's protocol ID
R7-A182
Acronym
PACT
Status last verified
Aug 2023
First submitted
14 Sep 2023
Last updated
8 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bjertrup A, Rasmussen KH, Torring S, Miskowiak KW. Targeting affective cognition during pregnancy to prevent postpartum depression: a randomized controlled trial with parity-specific effects. Eur Neuropsychopharmacol. 2026 Oct 18;114:113885. doi: 10.1016/j.euroneuro.2026.113885. Online ahead of print.

    PubMed 42893683
  • Bjertrup AJ, Kofoed J, Egmose I, Wendelboe K, Southgate V, Vaever MS, Miskowiak KW. Prenatal affective cognitive training to reduce the risk of postpartum depression (PACT): study protocol for a randomized controlled trial. Trials. 2024 Jul 15;25(1):478. doi: 10.1186/s13063-024-08316-1.

    PubMed 39010232

Questions about this trial

What is this clinical trial studying?

A study testing Prenatal Affective CogntiiveTraining in people with Postpartum Depression and Emotional Regulation, run by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 17 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anne J Bjertrup, PhD (27134839, anne.juul.bjertrup@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of PPD during the first six months after birth, assessed with the Present State Examination (PSE), which is a part of Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (time frame: Six months after birth). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06046456, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in